Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans
Launched by HEINRICH-HEINE UNIVERSITY, DUESSELDORF · May 5, 2023
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding a condition called aortic stenosis, where the heart's aortic valve becomes narrowed, making it harder for the heart to pump blood. Researchers want to learn more about the signs (called biomarkers) and processes that lead to this disease getting worse. By studying images of the heart and other factors, they hope to find out which patients are at higher risk and to explore new treatment options.
To participate in this study, you need to be at least 18 years old and have a moderate case of aortic stenosis, which means you are receiving regular care from a heart doctor. Unfortunately, if you have serious issues that would prevent certain types of imaging tests or if your aortic stenosis is too mild or severe, you may not be eligible. If you join the study, you will be informed about the procedures and will need to give your written consent. The trial is not yet recruiting participants, but it aims to gather important information that could improve care for those with this heart condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient has an acquired (tricuspid) moderate aortic valve stenosis, which is the reason for regular outpatient cardiological care.
- • The subject has been informed verbally and in writing about the study and has given written consent to participate in this study.
- • Age \> 18 years
- Exclusion Criteria:
- • The subject has contraindications for the performance of a magnetic resonance imaging or computed tomography (e.g., severe arrhythmias , contrast agent intolerance, a pacemaker, or severe renal insufficiency or severe renal insufficiency or claustrophobia).
- • Presence of only mild or already high-grade acquired tricuspid Aortic valve stenosis
- • Patient with bicuspid aortic valve
- • Inability to follow the instructions of study personnel
- • Lack of written informed consent
About Heinrich Heine University, Duesseldorf
Heinrich-Heine University Düsseldorf is a leading academic institution dedicated to advancing medical research and education. Renowned for its innovative approach to healthcare and interdisciplinary collaboration, the university plays a pivotal role in clinical trials aimed at improving patient outcomes and translating scientific discoveries into clinical practice. With a robust infrastructure and a commitment to ethical standards, Heinrich-Heine University fosters an environment that supports cutting-edge research initiatives, contributing significantly to the advancement of medical knowledge and therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cologne, , Germany
Düsseldorf, , Germany
Bonn, , Germany
Patients applied
Trial Officials
Malte Kelm, Prof.
Study Chair
Clinic for Cardiology, Pneumology and Angiology at University Hospital Düsseldorf
Georg Nickenig, Prof.
Study Chair
University Bonn
Stephan Baldus, Prof.
Study Chair
University Cologne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported